Hermankova Monika, Siliciano Janet D, Zhou Yan, Monie Daphne, Chadwick Karen, Margolick Joseph B, Quinn Thomas C, Siliciano Robert F
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Virol. 2003 Jul;77(13):7383-92. doi: 10.1128/jvi.77.13.7383-7392.2003.
In individuals with human immunodeficiency virus type 1 (HIV-1) infection, a small reservoir of resting memory CD4(+) T lymphocytes carrying latent, integrated provirus persists even in patients treated for prolonged periods with highly active antiretroviral therapy (HAART). This reservoir greatly complicates the prospects for eradicating HIV-1 infection with antiretroviral drugs. Therefore, it is critical to understand how HIV-1 latency is established and maintained. In particular, it is important to determine whether transcriptional or posttranscriptional mechanisms are involved. Therefore, HIV-1 DNA and mRNAs were measured in highly purified populations of resting CD4(+) T lymphocytes from the peripheral blood of patients on long-term HAART. In such patients, the predominant form of persistent HIV-1 is latent integrated provirus. Typically, 100 HIV-1 DNA molecules were detected per 10(6) resting CD4(+) T cells. Only very low levels of unspliced HIV-1 RNA ( approximately 50 copies/10(6) resting CD4(+) T cells) were detected using a reverse transcriptase PCR assay capable of detecting a single molecule of RNA standard. Levels of multiply spliced HIV-1 RNA were below the limit of detection (<50 copies/10(6) cells). Only 1% of the HIV-1 DNA-positive lymphocytes in this compartment could be induced to up-regulate HIV-1 mRNAs after cellular activation, indicating that most of the proviral DNA in resting CD4(+) T cells either carries intrinsic defects precluding transcription or is subjected to transcriptional control mechanisms that preclude high-level production of multiply spliced mRNAs. Nevertheless, by inducing T-cell activation, it is possible to isolate replication-competent virus from resting CD4(+) T lymphocytes of all infected individuals, including those on prolonged HAART. Thus, a subset of integrated proviruses (1%) remains competent for high-level mRNA production after cellular activation, and a subset of these can produce infectious virus. Measurements of steady-state levels of multiply spliced and unspliced HIV-1 RNA prior to cellular activation suggest that infected resting CD4(+) T lymphocytes in blood synthesize very little viral RNA and are unlikely to be capable of producing virus. In these cells, latency appears to reflect regulation at the level of mRNA production rather than at the level of splicing or nuclear export of viral mRNAs.
在感染1型人类免疫缺陷病毒(HIV-1)的个体中,即使是接受高效抗逆转录病毒疗法(HAART)长期治疗的患者,仍有一小部分携带潜伏整合前病毒的静止记忆CD4(+) T淋巴细胞库持续存在。这个细胞库极大地增加了用抗逆转录病毒药物根除HIV-1感染前景的复杂性。因此,了解HIV-1潜伏状态如何建立和维持至关重要。特别是,确定转录或转录后机制是否参与其中很重要。因此,对长期接受HAART治疗患者外周血中高度纯化的静止CD4(+) T淋巴细胞群体中的HIV-1 DNA和mRNA进行了测量。在这类患者中,持续存在的HIV-1的主要形式是潜伏整合前病毒。通常,每10(6)个静止CD4(+) T细胞中可检测到100个HIV-1 DNA分子。使用能够检测单分子RNA标准品的逆转录酶PCR检测法,仅检测到极低水平的未剪接HIV-1 RNA(约50拷贝/10(6)个静止CD4(+) T细胞)。多重剪接的HIV-1 RNA水平低于检测限(<50拷贝/10(6)个细胞)。在这个细胞区室中,只有1%的HIV-1 DNA阳性淋巴细胞在细胞活化后可被诱导上调HIV-1 mRNA,这表明静止CD4(+) T细胞中的大多数前病毒DNA要么存在阻止转录的内在缺陷,要么受到阻止多重剪接mRNA高水平产生的转录控制机制的影响。然而,通过诱导T细胞活化,有可能从所有感染个体(包括长期接受HAART治疗的个体)的静止CD4(+) T淋巴细胞中分离出具有复制能力的病毒。因此,一部分整合前病毒(1%)在细胞活化后仍有能力进行高水平的mRNA产生,其中一部分能够产生感染性病毒。在细胞活化前对多重剪接和未剪接HIV-1 RNA的稳态水平进行测量表明,血液中受感染的静止CD4(+) T淋巴细胞合成的病毒RNA极少,不太可能产生病毒。在这些细胞中,潜伏状态似乎反映了mRNA产生水平的调控,而不是病毒mRNA剪接或核输出水平的调控。